Source: EURLEX
Language: en
Format: md

Judgment of the General Court (Second Chamber) of 8 September 2021 –  
Cara Therapeutics v EUIPO – Gebro Holding (KORSUVA)

(Case T‑584/20)

(EU trade mark – Opposition proceedings – Application for the EU word mark KORSUVA – Earlier national word mark AROSUVA – Relative ground for refusal – Likelihood of confusion – Article 8(1)(b) of Regulation (EU) 2017/1001)

| 1. | EU trade mark – Definition and acquisition of the EU trade mark – Relative grounds for refusal – Opposition by the proprietor of an earlier identical or similar mark registered for identical or similar goods or services – Likelihood of confusion with the earlier mark – Criteria for assessment  (European Parliament and Council Regulation 2017/1001, Art. 8(1)(b))  (see paras 17, 18, 22, 41) |

| 2. | EU trade mark – Definition and acquisition of the EU trade mark – Relative grounds for refusal – Opposition by the proprietor of an earlier identical or similar mark registered for identical or similar goods or services – Similarity of the marks concerned – Identical number of letters composing two word marks – Presence of several letters in the same order  (European Parliament and Council Regulation 2017/1001, Art. 8(1)(b))  (see paras 26, 27, 29, 30, 35) |

| 3. | EU trade mark – Definition and acquisition of the EU trade mark – Relative grounds for refusal – Opposition by the proprietor of an earlier identical or similar mark registered for identical or similar goods or services – Likelihood of confusion with the earlier mark – Word marks KORSUVA and AROSUVA  (European Parliament and Council Regulation 2017/1001, Art. 8(1)(b))  (see paras 31, 34, 36, 42-44) |

Re:

Action brought against the decision of the Fourth Board of Appeal of EUIPO of 3 July 2020 (Case R 2450/2019-4), relating to opposition proceedings between Gebro Holding and Cara Therapeutics.

Operative part

The Court:

| 1. | Dismisses the action; |

| 2. | Orders Cara Therapeutics, Inc. to pay the costs. |

[Top](#document1)